Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).
BACKGROUND
The contribution of reproductive hormones to mood has been the focus of considerable research. Results from clinical and epidemiological studies have been inconsistent. It remains unclear whether alterations in serum hormone levels across the menopausal transition are linked to depressive symptoms.


OBJECTIVE
To evaluate the relationship between serum hormone levels and high depressive symptoms and whether hormone levels or their change might explain the association of menopausal status with depressive symptoms previously reported in a national sample of midlife women.


METHODS
A longitudinal, community-based, multisite study of menopause. Data were collected at baseline and annually from December 1995 to January 2008 on a range of factors. Early follicular phase serum samples were assayed for levels of estradiol, follicle-stimulating hormone, testosterone, and dehydroepiandrosterone sulfate.


METHODS
Seven communities nationwide.


METHODS
A community-based sample of 3302 multiethnic women, aged 42 to 52 years, still menstruating and not using exogenous reproductive hormones. Main Outcome Measure Depressive symptoms assessed with the Center for Epidemiological Studies Depression Scale (CES-D). The primary outcome was a CES-D score of 16 or higher.


RESULTS
In multivariable random-effects logistic regression models, log-transformed testosterone level was significantly positively associated with higher odds of a CES-D score of 16 or higher (odds ratio = 1.15; 95% confidence interval, 1.01-1.31) across 8 years, and a larger increase in log-transformed testosterone from baseline to each annual visit was significantly associated with increased odds of a CES-D score of 16 or higher (odds ratio = 1.23; 95% confidence interval, 1.04-1.45). Less education, being Hispanic, and vasomotor symptoms, stressful life events, and low social support at each visit were each independently associated with a CES-D score of 16 or higher. No other hormones were associated with a CES-D score of 16 or higher. Being perimenopausal or postmenopausal compared with being premenopausal remained significantly associated with a CES-D score of 16 or higher in all analyses.


CONCLUSIONS
Higher testosterone levels may contribute to higher depressive symptoms during the menopausal transition. This association is independent of menopausal status, which remains an independent predictor of higher depressive symptoms.
Bromberger
Joyce T
JT
University of Pittsburgh, Pittsburgh, PA 15213, USA. brombergerjt@upmc.edu
Schott
Laura L
LL
Kravitz
Howard M
HM
Sowers
Maryfran
M
Avis
Nancy E
NE
Gold
Ellen B
EB
Randolph
John F
JF
Matthews
Karen A
KA
D000328:Adult; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D003863:Depression / Q000097:blood* / Q000175:diagnosis / Q000453:epidemiology; D003866:Depressive Disorder / Q000097:blood / Q000175:diagnosis; D004958:Estradiol / Q000097:blood*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D008137:Longitudinal Studies; D008593:Menopause / Q000097:blood* / Q000523:psychology; D008875:Middle Aged; D016017:Odds Ratio; D017698:Postmenopause / Q000097:blood; D017697:Premenopause / Q000097:blood; D011569:Psychiatric Status Rating Scales; D013739:Testosterone / Q000097:blood*; D014481:United States / Q000453:epidemiology; D016387:Women's Health
D013739:Testosterone; D004958:Estradiol; D019314:Dehydroepiandrosterone Sulfate; D005640:Follicle Stimulating Hormone